NYSE:ABT
Abbott Laboratories Stock News
$105.90
-3.31 (-3.03%)
At Close: Apr 17, 2024
Abbott Labs Stock Falls as Q2 Guidance Outweighs Earnings Beat
02:25pm, Wednesday, 17'th Apr 2024
Shares of Abbott Laboratories (ABT) fell in intraday trading Wednesday, with second-quarter guidance seeming to outweigh first-quarter results that beat analyst estimates.
Q1 Earnings Review
12:05pm, Wednesday, 17'th Apr 2024
Pre-market futures are up slightly at this hour. Markets look to rebound off a three-day losing streak on the S&P 500 and Nasdaq; the blue-chip Dow outperformed the field yesterday, closing +0.17%.
Markets Try to Shake Off April Blues
11:36am, Wednesday, 17'th Apr 2024
Late March highs -- including all-time S&P levels -- have given way to profit-taking and existential concerns.
Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract
11:16am, Wednesday, 17'th Apr 2024
Abbott (ABT) delivers double-digit organic sales growth in its underlying base business in the first quarter of 2024.
Abbott (ABT) Reports Q1 Earnings: What Key Metrics Have to Say
10:31am, Wednesday, 17'th Apr 2024
Although the revenue and EPS for Abbott (ABT) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street es
Abbott (ABT) Tops Q1 Earnings and Revenue Estimates
09:41am, Wednesday, 17'th Apr 2024
Abbott (ABT) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $1.03 per share a year ago.
Abbott beats estimates, reports a 2.2% rise in Q1 sales
09:39am, Wednesday, 17'th Apr 2024
Abbott Laboratories on April 17 reported a 2.2% rise of $10 billion in its 2024 first-quarter sales which includes the impact of the anticipated decline in COVID-19 testing-related sales as compared t
Abbott Labs Stock Is Slipping. Disappointing Guidance Trumps a Strong Quarter.
08:41am, Wednesday, 17'th Apr 2024
Healthcare-products firm Abbott Laboratories' first-quarter earnings beat expectations, but second-quarter guidance was light.
Abbott Labs first-quarter results top estimates amid strong medical device sales
07:45am, Wednesday, 17'th Apr 2024
Abbott Laboratories on Wednesday reported first-quarter sales and profit that topped expectations amid strength in its medical-device business. The healthcare-products company reported first-quarter n
Abbott beats quarterly profit estimates on strong medical device sales
07:34am, Wednesday, 17'th Apr 2024
Abbott Laboratories beat Wall Street estimates for quarterly profit on Wednesday and raised the lower end of its forecast, as robust demand for medical procedures boosted sales of its devices, includi
Markets Mixed as Q1 Earnings, Powell Control News Headlines
07:16pm, Tuesday, 16'th Apr 2024
Wednesday morning brings us more Q1 earnings reports, including from Abbott Labs (ABT) and U.S. Bancorp (USB).
After Nearly A 20% Rise In Six Months Will Abbott Stock See Higher Levels Post Q1?
11:30am, Monday, 15'th Apr 2024
Abbott (NYSE: ABT) will report its Q1 2024 results on Wednesday, April 17. We expect the company to post revenue of $9.9 billion and earnings of $0.95 on a per share and adjusted basis, aligning with
3 Buy Rated Stocks to Consider as Earnings Approach
10:01pm, Friday, 12'th Apr 2024
Several top-rated Zacks stocks are standing out before their first-quarter earnings report next week and here are three to consider.
What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?
10:56am, Friday, 12'th Apr 2024
Abbott (ABT) is likely to have progressed with its initiative to commercialize several biosimilars in emerging markets.
Ahead of Abbott (ABT) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
10:21am, Friday, 12'th Apr 2024
Evaluate the expected performance of Abbott (ABT) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for